CVM vs FBRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FBRX Captures Institutional Edge (3โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Forte Biosciences, Inc. Common Stock (FBRX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation. Fundamentally, CVM trades at 23.0x Forward P/E with 0.0% operating margin (-62.7% YoY revenue) versus FBRX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against FBRX sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CVM Revenue | FBRX Revenue | CVM Op. Margin | FBRX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2011 | $0M | N/A | -1881.0% | N/A | CVM |
| FY2012 | $0M | N/A | -6772.3% | N/A | CVM |
| FY2013 | $0M | N/A | -12450.1% | N/A | CVM |
| FY2014 | $0M | N/A | -9721.4% | N/A | CVM |
| FY2016 | N/A | $0M | N/A | -64673.5% | FBRX |
| FY2017 | N/A | $0M | N/A | -91775.6% | FBRX |
| FY2018 | N/A | $20M | N/A | -254.2% | FBRX |
| FY2019 | N/A | $0M | N/A | -11288.9% | FBRX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CVM | FBRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $20.9M | $1.6B | Larger Scale | FBRX |
| Trailing P/E Ratio Valuation | 23.0x | N/M | Lower Multiple | CVM |
| Forward P/E Ratio Valuation | 23.0x | N/M | Lower Multiple | CVM |
| Revenue Growth (YoY) Growth | -62.7% | +0.0% | Higher Growth | FBRX |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -252.5% | -62.3% | Higher ROE | FBRX |
| 52-Week Range Position Momentum | 10% ($1โ$8) | 100% ($10โ$77) | Stronger Trend | FBRX |
| Beta / 30D Volatility Risk Regime | 0.65ฮฒ ยท 120% Vol | 1.09ฮฒ ยท 3% Vol | Lower Realized Risk | FBRX |
| Unified Institutional Score Composite Signal | 56.6 / 100 (HOLD) | 52.7 / 100 (HOLD) | Higher Composite | CVM |